COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022.


Journal

JAMA internal medicine
ISSN: 2168-6114
Titre abrégé: JAMA Intern Med
Pays: United States
ID NLM: 101589534

Informations de publication

Date de publication:
01 10 2022
Historique:
pubmed: 9 9 2022
medline: 6 10 2022
entrez: 8 9 2022
Statut: ppublish

Résumé

Understanding risk factors for hospitalization in vaccinated persons and the association of COVID-19 vaccines with hospitalization rates is critical for public health efforts to control COVID-19. To determine characteristics of COVID-19-associated hospitalizations among vaccinated persons and comparative hospitalization rates in unvaccinated and vaccinated persons. From January 1, 2021, to April 30, 2022, patients 18 years or older with laboratory-confirmed SARS-CoV-2 infection were identified from more than 250 hospitals in the population-based COVID-19-Associated Hospitalization Surveillance Network. State immunization information system data were linked to cases, and the vaccination coverage data of the defined catchment population were used to compare hospitalization rates in unvaccinated and vaccinated individuals. Vaccinated and unvaccinated patient characteristics were compared in a representative sample with detailed medical record review; unweighted case counts and weighted percentages were calculated. Laboratory-confirmed COVID-19-associated hospitalization, defined as a positive SARS-CoV-2 test result within 14 days before or during hospitalization. COVID-19-associated hospitalization rates among vaccinated vs unvaccinated persons and factors associated with COVID-19-associated hospitalization in vaccinated persons were assessed. Using representative data from 192 509 hospitalizations (see Table 1 for demographic information), monthly COVID-19-associated hospitalization rates ranged from 3.5 times to 17.7 times higher in unvaccinated persons than vaccinated persons regardless of booster dose status. From January to April 2022, when the Omicron variant was predominant, hospitalization rates were 10.5 times higher in unvaccinated persons and 2.5 times higher in vaccinated persons with no booster dose, respectively, compared with those who had received a booster dose. Among sampled cases, vaccinated hospitalized patients with COVID-19 were older than those who were unvaccinated (median [IQR] age, 70 [58-80] years vs 58 [46-70] years, respectively; P < .001) and more likely to have 3 or more underlying medical conditions (1926 [77.8%] vs 4124 [51.6%], respectively; P < .001). In this cross-sectional study of US adults hospitalized with COVID-19, unvaccinated adults were more likely to be hospitalized compared with vaccinated adults; hospitalization rates were lowest in those who had received a booster dose. Hospitalized vaccinated persons were older and more likely to have 3 or more underlying medical conditions and be long-term care facility residents compared with hospitalized unvaccinated persons. The study results suggest that clinicians and public health practitioners should continue to promote vaccination with all recommended doses for eligible persons.

Identifiants

pubmed: 36074486
pii: 2796235
doi: 10.1001/jamainternmed.2022.4299
pmc: PMC9459904
doi:

Substances chimiques

COVID-19 Vaccines 0
Influenza Vaccines 0

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1071-1081

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Références

MMWR Morb Mortal Wkly Rep. 2022 Mar 25;71(12):466-473
pubmed: 35324880
MMWR Morb Mortal Wkly Rep. 2022 Jan 07;71(1):19-25
pubmed: 34990440
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464
pubmed: 32298251
JAMA. 2021 Nov 23;326(20):2043-2054
pubmed: 34734975
Clin Infect Dis. 2022 Dec 19;75(12):2161-2168
pubmed: 35511586
MMWR Morb Mortal Wkly Rep. 2022 Feb 18;71(7):271-278
pubmed: 35176003
N Engl J Med. 2022 Mar 17;386(11):1094
pubmed: 35172053
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1088-1093
pubmed: 34383730
MMWR Morb Mortal Wkly Rep. 2021 Nov 05;70(44):1545-1552
pubmed: 34735422
MMWR Morb Mortal Wkly Rep. 2022 Aug 26;71(34):1085-1091
pubmed: 36006841
Ann Intern Med. 2021 Oct;174(10):1409-1419
pubmed: 34370517
N Engl J Med. 2022 Apr 14;386(15):1397-1408
pubmed: 35172054
Clin Microbiol Infect. 2021 Nov;27(11):1652-1657
pubmed: 34245907
JAMA Netw Open. 2021 Oct 1;4(10):e2130479
pubmed: 34673962
medRxiv. 2021 Jul 08;:
pubmed: 34268515
MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1294-1299
pubmed: 34529636
N Engl J Med. 2021 Jul 22;385(4):320-329
pubmed: 34192428

Auteurs

Fiona P Havers (FP)

US Centers for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia.
Public Health Service Commissioned Corps, Rockville, Maryland.

Huong Pham (H)

US Centers for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia.

Christopher A Taylor (CA)

US Centers for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia.

Michael Whitaker (M)

US Centers for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia.

Kadam Patel (K)

US Centers for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia.
General Dynamics Information Technology, Atlanta, Georgia.

Onika Anglin (O)

US Centers for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia.
General Dynamics Information Technology, Atlanta, Georgia.

Anita K Kambhampati (AK)

US Centers for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia.

Jennifer Milucky (J)

US Centers for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia.

Elizabeth Zell (E)

US Centers for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia.
Stat-Epi Associates, Inc, Ponte Vedra Beach, Florida.

Heidi L Moline (HL)

US Centers for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia.
Public Health Service Commissioned Corps, Rockville, Maryland.

Shua J Chai (SJ)

Field Services Branch, Division of State and Local Readiness, Center for Preparedness and Response, US Centers for Disease Control and Prevention, Atlanta, Georgia.
California Emerging Infections Program, Oakland.

Pam Daily Kirley (PD)

California Emerging Infections Program, Oakland.

Nisha B Alden (NB)

Colorado Department of Public Health and Environment, Denver.

Isaac Armistead (I)

Colorado Department of Public Health and Environment, Denver.

Kimberly Yousey-Hindes (K)

Connecticut Emerging Infections Program, Yale School of Public Health, New Haven.

James Meek (J)

Connecticut Emerging Infections Program, Yale School of Public Health, New Haven.

Kyle P Openo (KP)

Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, Georgia.
Georgia Emerging Infections Program, Georgia Department of Public Health, Atlanta.

Evan J Anderson (EJ)

Georgia Emerging Infections Program, Georgia Department of Public Health, Atlanta.
Departments of Medicine and Pediatrics, Emory School of Medicine, Atlanta, Georgia.
Atlanta Veterans Affairs Medical Center, Atlanta, Georgia.

Libby Reeg (L)

Michigan Department of Health and Human Services, Lansing.

Alexander Kohrman (A)

Michigan Department of Health and Human Services, Lansing.

Ruth Lynfield (R)

Minnesota Department of Health, St. Paul.

Kathryn Como-Sabetti (K)

Minnesota Department of Health, St. Paul.

Elizabeth M Davis (EM)

New Mexico Department of Health, Santa Fe.

Cory Cline (C)

New Mexico Department of Health, Santa Fe.

Alison Muse (A)

New York State Department of Health, Albany.

Grant Barney (G)

New York State Department of Health, Albany.

Sophrena Bushey (S)

University of Rochester School of Medicine and Dentistry, Rochester, New York.

Christina B Felsen (CB)

University of Rochester School of Medicine and Dentistry, Rochester, New York.

Laurie M Billing (LM)

Ohio Department of Health, Columbus.

Eli Shiltz (E)

Ohio Department of Health, Columbus.

Melissa Sutton (M)

Public Health Division, Oregon Health Authority, Portland.

Nasreen Abdullah (N)

Public Health Division, Oregon Health Authority, Portland.

H Keipp Talbot (HK)

Vanderbilt University Medical Center, Nashville, Tennessee.

William Schaffner (W)

Vanderbilt University Medical Center, Nashville, Tennessee.

Mary Hill (M)

Salt Lake County Health Department, Salt Lake City, Utah.

Andrea George (A)

Salt Lake County Health Department, Salt Lake City, Utah.

Aron J Hall (AJ)

US Centers for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia.

Stephanie R Bialek (SR)

US Centers for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia.
Public Health Service Commissioned Corps, Rockville, Maryland.

Neil C Murthy (NC)

US Centers for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia.
Public Health Service Commissioned Corps, Rockville, Maryland.

Bhavini Patel Murthy (BP)

US Centers for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia.
Public Health Service Commissioned Corps, Rockville, Maryland.

Meredith McMorrow (M)

US Centers for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia.
Public Health Service Commissioned Corps, Rockville, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH